1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>Japan

Japan Regulators Kept On Track Despite Pandemic

First Annual Price Cut Lies Ahead

 
• By Ian Haydock

While it was not as affected as some other countries, Japan still had the pandemic to deal with and regulators responded while managing to keep up regular product review work, including several world-first approvals. Coronavirus vaccine roll-outs and the first general annual reimbursement price cut are on the cards for this year. 

Tokyo Dog
The Famous Statue Of 'Hachiko' In Shibuya, Tokyo. Japan's Drug Regulators Also Remained Vigilant In A Challenging Year. • Source: Shutterstock

While the situation in 2020 was not as bad as in some other countries, Japan like the rest of the world has been grappling with the coronavirus outbreak. In the pharma policy and regulatory sphere, this meant recognizing the situation, adapting, and enacting change where impactful.

The most obvious response came in public declarations from the country’s main regulatory bodies, the Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency (PMDA), that they would spare no effort in expediting

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia